Skip to main content
. 2019 Apr 5;9:5662. doi: 10.1038/s41598-019-42076-2

Figure 1.

Figure 1

Antigen/vaccine structures and conjugation procedures used in this work. (A) structure of the 16-residue tandem repeat peptide from MUC4 with a TFag at position Ser5 (5TFag-TRMUC4) and the PEG linker used to conjugate to gold nanoparticles to construct our vaccine platform (shown), as well as to prepare KLH and BSA conjugates (B).